Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

More On PATZF

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates
  • Research Reports

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Patrys Limited (PATZF)

-Other OTC
0.03 0.00(0.00%) Apr 4, 3:19PM EDT
Get the big picture on all your investments.
ProfileGet Profile for:
Patrys Limited
Equitable House
Level 6
Melbourne, VIC 3000
Australia - Map
Phone: 61 3 9670 3273
Fax: 61 3 9670 3247
Website: http://www.patrys.com

Details 
Index Membership:N/A
Sector:N/A
Industry:N/A
Full Time Employees:12

Business Summary 

Patrys Limited, a clinical stage biotechnology company, together with its subsidiaries, develops natural human antibodies as therapies for cancer and other major diseases in Australia. The company’s clinical products include PAT-SM6, a natural human antibody used for the treatment of multiple types of cancer, including solid tumors, such as melanoma, breast, colon, and pancreatic, as well as blood-based cancers that include multiple myeloma; and PAT-SC1 for treating gastric cancer and solid tumors. It also has late stage preclinical products, such as PAT-LM1, a natural human antibody that is used in the treatment for multiple types of cancer against colon, lung, breast, ovary, and pancreatic cancers. The company was founded in 2006 and is headquartered in Melbourne, Australia.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Patrys Limited

Key Executives 
 PayExercised
Dr. Marie Roskrow BSc. (Hons), MBBS (Hons), Ph.D.,
Chief Exec. Officer, Managing Director and Exec. Director
380.00KN/A
Mr. Roger McPherson CPA, GAICD,
Chief Financial Officer and Company Sec.
278.00KN/A
Dr. Deanne Greenwood Ph.D., MBA,
Sr. Director of Bus. Devel.
N/AN/A
Dr. Frank Hensel Ph.D.,
VP of R&D and Managing Director of Patrys GmbH
N/AN/A
Dr. Stephanie Br ,
Scientific Advisor
N/AN/A
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.